In this Drug Discovery World feature article, our CEO, Dan Passeri, shares insights on the potential of our Immuno-STAT™ platform and pipeline for the treatment of #cancer. Thank you Drug Discovery World for the spotlight! Click the link below to learn more.
Harnessing nature’s ‘cues’ in the treatment of cancer Megan Thomas spoke with Daniel Passeri, CEO of Cue Biopharma, about why the company’s pipeline of cytokine-based drugs are so promising for cancer treatment. https://lnkd.in/egxHr87f #Cancer #CancerResearch #Oncology